Alpha-Glucosidase Inhibitors
work to control diabetes by inhibitign the enzymes that break down starches
and carbohydrates in the body, lowering the necessity for insulin.
This is accomplished through competitive, reversible inhibition of pancreatic
alpha amylase and membrane bound intestinal alpha glucoside hydrolase enzymes.
The drug is metabolized by the digestive enzymes in the intestine and also
by the intestinal bacteria. The pancreatic alpha-amylase breaks down starches
(the food storage units in plants) to smaller sugar units, oligosaccharides
within the small intestine. The membrane bound intestinal alpha glucosidases
hydrolyze oligosaccharides, trisaccharides, and disaccharides to glucose
and other monomer sugars in the small intestine. The result of inhibiting
these enzymes is delayed and lowered glucose absorption. The inhibitory
activity also works against lactase, but has not been shown to induce lactose
intolerance, the inability to break down the lactose molecule. The mechanism
that is inhibited by this drug is shown below.
|
|
|
|
|
|
Acarbose